The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Antenatal Screening for Down's Syndrome
Open accessAbstract
BACKGROUND: In 1968 the first antenatal diagnosis of Down's syndrome was made and screening on the basis of selecting women of advanced maternal age for amniocentesis was gradually introduced into medical practice. In 1983 it was shown that low maternal serum alpha fetoprotein (AFP) was associated with Down's syndrome. Later, raised maternal serum human chorionic gonadotrophin (hCG), and low unconjugated oestriol (uE3) were found to be markers of Down's syndrome. In 1988 the three biochemical markers were used together with maternal age as a method of screening, and this has been widely adopted. PRINCIPLES OF ANTENATAL SCREENING FOR DOWN'S SYNDROME: Methods of screening need to be fully evaluated before being introduced into routine clinical practice. This included choosing markers for which there is sufficient scientific evidence of efficacy, quantifying performance in terms of detection and false positive rates, and establishing methods of monitoring performance. Screening needs to be provided as an integrated service, coordinating and managing the separate aspects of the screening process. SERUM MARKERS AT 15-22 WEEKS OF PREGNANCY: A large number of serum markers have been found to be associated with Down's syndrome between 15 and 22 weeks of pregnancy. The principal markers are AFP, hCG or its individual subunits (free alpha- and free beta-hCG), uE3, and inhibin A. Screening performance varies according to the choice of markers used and whether ultrasound is used to estimate gestational age (table 1). When an ultrasound scan is used to estimate gestational age the detection rate for a 5% false positive rate is estimated to be 59% using the double test (AFP and hCG), 69% using the triple test (AFP, hCG, uE3), and 76% using the quadruple test (AFP, hCG, uE3, inhibin A), all in combination with maternal age. Other factors that can usefully be taken into account in screening are maternal weight, the presence of insulin dependent diabetes mellitus, multiple pregnancy, ethnic origin, previous Down's syndrome pregnancy, and whether the test is the first one in a pregnancy or a repeat. Factors such as parity and smoking are associated with one or more of the serum markers, but the effect is too small to justify adjusting for these factors in interpreting a screening test. URINARY MARKERS AND FETAL CELLS IN MATERNAL BLOOD: Urinary beta-core hCG has been investigated in a number of studies and shown to be raised in pregnancies with Down's syndrome. This area is currently the subject of active research and the use of urine in future screening programmes may be a practical possibility. Other urinary markers, such as total oestriol and free beta-hCG may also be of value. Fetal cells can be identified in the maternal circulation and techniques such as fluorescent in situ hybridisation can be used to identify aneuploidies, including Down's syndrome and trisomy 18. This approach may, in the future, be of value in screening or diagnosis. Currently, the techniques available do not have the performance, simplicity, or economy needed to replace existing methods. DEMONSTRATION PROJECTS: Demonstration projects are valuable in determining the feasibility of screening and in refining the practical application of screening. They are of less value in determining the performance of different screening methods. Several demonstration projects have been conducted using the triple and double tests. In general, the uptake of screening was about 80%. The screen positive rates were about 5-6%. About 80% of women with positive screening results had an invasive diagnostic test, and of those found to have a pregnancy with Down's syndrome, about 90% chose to have a termination of pregnancy. ULTRASOUND MARKERS AT 15-22 WEEKS OF PREGNANCY: There are a number of ultrasound markers of Down's syndrome at 15-22 weeks, including nuchal fold thickness, cardiac abnormalities, duodenal atresia, femur length, humerus length, pyelectasis, and hyperechogenic bowel. (ABSTRA
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Nicolaides, K. H., Azar, G., Byrne, D., Mansur, C., & Marks, K. (1992) · BMJ · doi:10.1136/bmj.304.6831.867 · Cited by 1,056
Maternal serum screening for Down's syndrome in early pregnancy.
Wald, N. J., Cuckle, H. S., Densem, J. W., Nanchahal, K., Royston, P., Chard, T., Haddow, J. E., Knight, G. J., Palomaki, G. E., & Canick, J. A. (1988) · BMJ · doi:10.1136/bmj.297.6653.883 · Cited by 966
Self-citationRANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN
Tabor, A., Madsen, M., Obel, E., Philip, J., Bang, J., & Gaard-Pedersen, B. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91218-3 · Cited by 869
An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities
Merkatz, I. R., Nitowsky, H. M., Macri, J. N., & Johnson, W. E. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90530-1 · Cited by 735
Emery and Rimoin's Principles and Practice of Medical Genetics
Woods, C. G. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.7.614-a · Cited by 712
CUCKLE, H. S., WALD, N. J., & THOMPSON, S. G. (1987) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1987.tb03115.x · Cited by 604
Self-citationALPHA-FETOPROTEIN IN THE ANTENATAL DIAGNOSIS OF ANENCEPHALY AND SPINA BIFIDA
Brock, D. J. H., & Sutcliffe, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91634-0 · Cited by 602
Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
Haddow, J. E., Palomaki, G. E., Knight, G. J., Williams, J., Pulkkinen, A., Canick, J. A., Saller, D. N., & Bowers, G. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270902 · Cited by 454
CHROMOSOME ANALYSIS OF HUMAN AMNIOTIC-FLUID CELLS
Steele, M., & Roy Breg, W. (1966) · The Lancet · doi:10.1016/s0140-6736(66)91387-0 · Cited by 447
Nicolaides, K. H., Brizot, M. L., & Snijders, R. J. M. (1994) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1994.tb11946.x · Cited by 351
Sonographic Identification of Second-Trimester Fetuses with Down's Syndrome
Benacerraf, B. R., Gelman, R., & Frigoletto, F. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172203 · Cited by 317
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome
CANICK, J. A., KNIGHT, G. J., PALOMAK1, G. E., HADDOW, J. E., CUCKLE, H. S., & WALD, N. J. (1988) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb06601.x · Cited by 306
Self-citationChitty, L. S., Hunt, G. H., Moore, J., & Lobb, M. O. (1991) · BMJ · doi:10.1136/bmj.303.6811.1165 · Cited by 292
Nicolaides, K., Brizot, M., Patel, F., & Snijders, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91769-8 · Cited by 271
A Randomized Comparison of Transcervical and Transabdominal Chorionic-Villus Sampling
Jackson, L. G., Zachary, J. M., Fowler, S. E., Desnick, R. J., Golbus, M. S., Ledbetter, D. H., Mahoney, M. J., Pergament, E., Simpson, J. L., Black, S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270903 · Cited by 271
Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency
Pandya, P. P., Kondylios, A., Hilbert, L., Snijders, R. J. M., & Nicolaides, K. H. (1995) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1995.05010015.x · Cited by 232
PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKER
WALD, N. J., DENSEM, J. W., GEORGE, L., MUTTUKRISHNA, S., & KNIGHT, P. G. (1996) · Prenatal Diagnosis · doi:10.1002/(sici)1097-0223(199602)16:2<143::aid-pd825>3.0.co;2-f · Cited by 231
Self-citationCarr, J. (1988) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1988.tb00734.x · Cited by 216
Macri, J. N., Kasturi, R. V., Krantz, D. A., Cook, E. J., Moore, N. D., Young, J. A., Romero, K., & Larsen, J. W. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90700-h · Cited by 214
Fetal pyelectasis: a possible association with Down syndrome.
Benacerraf, B. R., Mandell, J., Estroff, J. A., Harlow, B. L., & FRIGOLETTO, F. D. (1990) · PubMed · Cited by 213
Abnormalities of thyroid function in infants with Down syndrome
Fort, P., Lifshitz, F., Bellisario, R., Davis, J., Lanes, R., Pugliese, M., Richman, R., Post, E. M., & David, R. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80544-2 · Cited by 212
WALD, N. J., CUCKLE, H. S., DENSEM, J. W., KENNARD, A., & SMITH, D. (1992) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb14474.x · Cited by 200
Self-citationSerum screening for Down's syndrome between 8 and 14 weeks of pregnancy
Wald, N. J., George, L., Smith, D., Densem, J. W., Pettersonm, K., & on behalf of the International Prenatal Screening Research Group (1996) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1996.tb09765.x · Cited by 199
Self-citationGÄNSHIRT‐AHLERT, D., BÖRJESSON‐STOLL, R., BURSCHYK, M., DOHR, A., GARRITSEN, H. S. P., HELMER, E., MINY, P., VELASCO, M., WALDE, C., PATTERSON, D., et al. (1993) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1993.tb00620.x · Cited by 198
Smidt-Jensen, S., Philip, J., Lundsteen, C., Permin, M., Zachary, J. M., & Fowler, S. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)92946-d · Cited by 189
Simpson, J. L. (1993) · JAMA · doi:10.1001/jama.270.19.2357 · Cited by 187
Spencer, K., Coombes, E. J., Mallard, A. S., & Ward, A. M. (1992) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329202900504 · Cited by 184
Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy
Aitken, D. A., Wallace, E. M., Crossley, J. A., Swanston, I. A., van Pareren, Y., van Maarle, M., Groome, N. P., Macri, J. N., & Connor, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605093341904 · Cited by 179
Analysis of limb reduction defects in babies exposed to chorionic villus sampling
Firth, H. V., Huson, S. M., Boyd, P. A., Chamberlain, P. F., MacKenzie, I., & Morriss-Kay, G. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90182-1 · Cited by 176
Sonographic scoring index for prenatal detection of chromosomal abnormalities
Benacerraf, B. R., Neuberg, D. S., Bromley, B., et al. (1992) · Journal of Ultrasound in Medicine · doi:10.7863/jum.1992.11.9.449 · Cited by 173
Model‐based screening by risk with application to down's syndrome
Royston, P., & Thompson, S. G. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110211 · Cited by 173
Prenatal sonographic findings of Down syndrome: Review of 94 cases
Nyberg, D., Resta, R., Luthy, D., Hickok, D., Mahoney, B., & Hirsch, J. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90112-i · Cited by 162
Marteau, T. M., Cook, R., Kidd, J., Michie, S., Johnston, M., Slack, J., & Shaw, R. W. (1992) · Prenatal Diagnosis · doi:10.1002/pd.1970120309 · Cited by 159
A sonographic screening method for Down syndrome
Lockwood, C. J., Benacerraf, B. R., Krinsky, A. H., Blakemore, K. J., Belanger, K. D., Mahoney, M., & Hobbins, J. C. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80059-5 · Cited by 150
Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice
Smith, D., Shaw, R. W., & Marteau, T. M. (1994) · BMJ · doi:10.1136/bmj.309.6957.776 · Cited by 149
First trimester fetal nuchal translucency: Problems with screening the general population 2.
Bewley, S., Roberts, L. J., Mackinson, A., & Rodeck, C. H. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb11290.x · Cited by 149
Brambati, B., Macintosh, M. C. M., Teisner, B., Maguiness, S. D., Shrimanker, K., LANZANI, A., Bonacchi, I., Tului, L., Chard, T., & Grudzinskas, J. G. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb12973.x · Cited by 146
First trimester prenatal diagnosis of trisomy 21 in fetal cells from maternal blood
Elias, S., Price, J. O., Dockter, M. E., Wachtel, S. S., Tharapel, A. T., Simpson, J. L., & Klinger, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93041-k · Cited by 138
LIFE EXPECTANCY IN DOWN SYNDROME ADULTS
Baird, P. A., & Sadovnick, A. S. D. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90881-1 · Cited by 134
First-trimester simple hygroma: Cause and outcome
Johnson, M. P., Johnson, A., Holzgreve, W., Isada, N. B., Wapner, R. J., Treadwell, M. C., Heeger, S., & Evans, M. I. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90906-0 · Cited by 132
REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTS
Neveux, L. M., PALOMAKI, G. E., LARRIVEE, D. A., Knight, G. J., & Haddow, J. E. (1996) · Prenatal Diagnosis · doi:10.1002/(sici)1097-0223(199612)16:12<1101::aid-pd5>3.0.co;2-7 · Cited by 132
REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTS
Neveux, L. M., PALOMAKI, G. E., LARRIVEE, D. A., Knight, G. J., & Haddow, J. E. (1996) · Prenatal Diagnosis · Cited by 131
A randomised trial of three methods of giving information about prenatal testing
Thornton, J., Hewison, J., Lilford, R. J., & Vail, A. (1995) · BMJ · doi:10.1136/bmj.311.7013.1127 · Cited by 129
O'Brien, J., Dvorin, E., Drugan, A., Johnson, M., Yaron, Y., & Evans, M. I. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00524-8 · Cited by 128
PRENATAL DIAGNOSIS OF DOWN'S SYNDROME
Valenti, C., Schutta, E., & Kehaty, T. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92656-1 · Cited by 124
Bronshtein, M., Rottem, S., Yoffe, N., & Blumenfeld, Z. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90237-8 · Cited by 123
Antenatal and neonatal screening
Cockburn, F. (1984) · Early Human Development · doi:10.1016/0378-3782(84)90128-2 · Cited by 122
Diagnosis and significance of cystic hygroma in the first trimester
Cullen, M. T., Gabrielli, S., Green, J. J., Rizzo, N., Mahoney, M. J., Salafia, C., Bovicelli, L., & Hobbins, J. C. (1990) · Prenatal Diagnosis · doi:10.1002/pd.1970101004 · Cited by 120
Second‐trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome
Lith, J. M. M. V., Pratt, J. J., Beekhuis, J. R., & Mantingh, A. (1992) · Prenatal Diagnosis · doi:10.1002/pd.1970121005 · Cited by 119
Serum screening for Down's syndrome: some women's experiences.
Statham, H., & Green, J. (1993) · BMJ · doi:10.1136/bmj.307.6897.174 · Cited by 117
Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis?
Bromley, B., Doubilet, P., FRIGOLETTO, F. D., et al. (1994) · PubMed · Cited by 116
Repeatability of measurement of fetal nuchal translucency thickness
Pandya, P. P., Altman, D. G., Brizot, M. D. L., Pettersen, H., & Nicolaides, K. H. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.05050334.x · Cited by 116
Free β-hCG as first-trimester marker for fetal trisomy
Spencer, K., Macri, J. N., Aitken, D. A., & Connor, J. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)92073-o · Cited by 111
First‐trimester diagnosis of nuchal anomalies: significance and fetal outcome
Ville, Y. G., Lalondrelle, C., Doumerc, S., Daffos, F., Frydman, R., Oury, J., & Dumez, Y. (1992) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1992.02050314.x · Cited by 96
Brambati, B., Cislaghi, C., Tului, L., Alberti, E., Amidani, M. M., Colombo, U., & Zuliani, G. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.05010009.x · Cited by 93
FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME
Cuckle, H., Wald, N., Barkai, G., Fuhrmann, W., Altland, K., Brambati, B., Knight, G. J., Palomaki, G. E., Haddow, J. E., & Canick, J. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92816-4 · Cited by 91
Self-citationBrizot, M. D. L., Snijders, R. J. M., Bersinger, N. A., Kühn, P., & Nicolaides, K. H. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)94898-p · Cited by 91
Nadel, A., Bromley, B., & Benacerraf, B. R. (1994) · Journal of diagnostic medical sonography · doi:10.1177/875647939401000132 · Cited by 90
Prevalence and Associated Features of Epilepsy in Adults with Down's Syndrome
McVicker, R. W., Shanks, O. E. P., & McClelland, R. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.528 · Cited by 90
Szabó, J., Gelén, J., & SZEMERE, G. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.05030161.x · Cited by 90
Brizot, M. D. L., Snijders, R. J. M., Butler, J., Bersinger, N. A., & Nicolaides, K. H. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb09065.x · Cited by 90
Ultrasound markers for fetal chromosomal defects
Whittle, M. J. (1996) · Early Human Development · doi:10.1016/0378-3782(96)88181-3 · Cited by 90
First trimester fetal nuchal translucency: Problems with screening the general population 1.
Roberts, L. J., Bewley, S., Mackinson, A., & Rodeck, C. H. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb11289.x · Cited by 90
FIRST TRIMESTER TRANSVAGINAL SONOGRAPHIC DIAGNOSIS OF FETAL ANOMALIES
Rottem, S., Bronshtein, M., Thaler, I., & Brandes, J. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90046-9 · Cited by 89
MULLER, F. M., Aegerter, P., & Boué, A. (1993) · Prenatal Diagnosis · doi:10.1002/pd.1970130106 · Cited by 87
SHULMAN, L. P., Emerson, D. S., Felker, R. E., Phillips, O. P., Simpson, J. L., & Elias, S. (1992) · PubMed · Cited by 78
Pandya, P. P., Goldberg, H., Walton, B., Riddle, A. F., Shelley, S., Snijders, R. J. M., & Nicolaides, K. H. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.05010020.x · Cited by 78
First-trimester diagnosis of cystic hygroma—Course and outcome
van Zalen-Sprock, R. M., van Vugt, J. M. G., & van Geijn, H. P. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91634-2 · Cited by 75
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A
Wallace, E. M., Swanston, I. A., McNeilly, A. S., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.544368.x · Cited by 75
Spencer, K., Aitken, D. A., Crossley, J. A., McCaw, G., Berry, E., Anderson, R., Connor, J. M., & Macri, J. N. (1994) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329403100504 · Cited by 74
Evaluation of maternal serum dimeric inhibin a as a first‐trimester marker of down's syndrome
Wallace, E. M., Grant, V., Swanston, I. A., & Groome, N. P. (1995) · Prenatal Diagnosis · doi:10.1002/pd.1970150410 · Cited by 69
Appraisal of a new scheme for prenatal screening for Down's syndrome.
Sheldon, T., & Simpson, J. (1991) · BMJ · doi:10.1136/bmj.302.6785.1133 · Cited by 68
Cuckle, H., Wald, N., Densem, J. W., Royston, P. J., Knight, G. J., Haddow, J. E., Palomaki, G. E., & Canick, J. A. (1990) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb01794.x · Cited by 68
Self-citationThe natural history of euploid pregnancies with first -trimester cystic hygromas
Trauffer, P. M. L., Anderson, C. E., Johnson, A., Heeger, S., Morgan, P., & Wapner, R. J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(13)90450-6 · Cited by 67
The accuracy of prenatal ultrasonography in detecting congenital anomalies
Gonçalves, L. F., Jeanty, P., & Piper, J. M. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90411-1 · Cited by 67
Palomaki, G. E., Knight, G. J., Haddow, J. E., Canick, J. A., Wald, N. J., & Kennard, A. (1993) · PubMed · Cited by 65
Self-citationAnxiety in women with low maternal serum alpha‐fetoprotein screening results
Abuelo, D. N., Hopmann, M. R., Barsel‐Bowers, G., & Goldstein, A. C. (1991) · Prenatal Diagnosis · doi:10.1002/pd.1970110607 · Cited by 64
First‐trimester nuchal edema as a marker of aneuploidy
Comas, C., Martínez, J. M., Ojuel, J., Casals, E., Puerto, B., BORRELL, A., & Fortuny, A. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.05010026.x · Cited by 64
Marteau, T. M., Kidd, J. M., Michie, S., Cook, R., Johnston, M., & Shaw, R. W. (1993) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674829309084441 · Cited by 61
Spencer, K., Wood, P. J., & Anthony, F. W. (1993) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329303000226 · Cited by 61
Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy
Savoldelli, G., Binkert, F., Achermann, J., & Schmid, W. (1993) · Prenatal Diagnosis · doi:10.1002/pd.1970130613 · Cited by 60
Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency
Hafner, E., Schuchter, K., & Philipp, K. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.06050330.x · Cited by 54
Bartels, I., Hoppe‐Sievert, B., Bockel, B., Herold, S., & Caesar, J. (1993) · Prenatal Diagnosis · doi:10.1002/pd.1970130207 · Cited by 54
Noble, P. L., Abraha, H. D., Snijders, R. J. M., Sherwood, R. A., & Nicolaides, K. H. (1995) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.1995.06060390.x · Cited by 53
Women's Experiences of Prenatal Serum Screening
Santalahti, P., Latikka, A., Ryynänen, M., & Hemminki, E. (1996) · Birth · doi:10.1111/j.1523-536x.1996.tb00837.x · Cited by 52
Bartels, I., & Lindemann, A. (1988) · Human Genetics · doi:10.1007/bf00451454 · Cited by 49
Bahado-Singh, R. O., Wyse, L., Dorr, M. A., Copel, J. A., O'Connor, T., & Hobbins, J. C. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)80029-9 · Cited by 46
MATERNAL SERUM-AFP AS SCREENING TEST FOR DOWN SYNDROME
Fuhrmann, W., Wendt, P., & Weitzel, H. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90585-3 · Cited by 45
Maternal serum inhibin levels in second‐trimester down's syndrome pregnancies
Cuckle, H., Holding, S., & Jones, R. (1994) · Prenatal Diagnosis · doi:10.1002/pd.1970140508 · Cited by 44
Non-echogenic nuchal oedema as a marker in trisomy 21 screening
Schulte-Vallentin, M., & Schindler, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90574-m · Cited by 43
Genetic amniocentesis in seventy twin pregnancies
Librach, C. L., Doran, T. A., Benzie, R. J., & Jones, J. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90753-1 · Cited by 42
Higurashi, M. (1995) · Brain and Development · doi:10.1016/0387-7604(95)90349-6 · Cited by 41
Yg, S., ECKL, C. J., Stinson, S., & Woods (1990) · PubMed · Cited by 41
Smith, D., Shaw, R. W., Slack, J., & Marteau, T. M. (1995) · Prenatal Diagnosis · doi:10.1002/pd.1970150404 · Cited by 40
Using decision analysis to compare policies for antenatal screening for Down's syndrome
Fletcher, J., Hicks, N., Kay, J. D., & Boyd, P. A. (1995) · BMJ · doi:10.1136/bmj.311.7001.351 · Cited by 40
Nuchal Translucency in the First Trimester
Hewitt, B. G. (1993) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1993.tb02117.x · Cited by 37
Piggott, M., Wilkinson, P. A., Bennett, J., & For the Brighton Eastbourne Down's Syndrome Screening Group (1994) · Journal of Medical Screening · doi:10.1177/096914139400100109 · Cited by 33
Keenan, K. L., Basso, D., Goldkrand, J. W., et al. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90624-z · Cited by 28
Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels
Kulch, P., Keener, S. L., Matsumoto, M., & Crandall, B. F. (1993) · Prenatal Diagnosis · doi:10.1002/pd.1970130306 · Cited by 25
Ashwood, E. R., Cheng, E., Luthy, D. A., et al. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260304 · Cited by 24
Marquette, G. P., Boucher, M., Desrochers, M., & Dallaire, L. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90636-l · Cited by 19
Maternal serum α‐fetoprotein, birthweight and perinatal death in twin pregnancy
Walker, E. M., & Patel, N. (1986) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb08646.x · Cited by 7
Simpson, J. L. (1993) · JAMA · doi:10.1001/jama.1993.03510190113036 · Cited by 4
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Self-citationWald, N. J., Rodeck, C., Hackshaw, A. K., Walters, J., Chitty, L., & Mackinson, A. M. (2003) · Health Technology Assessment · doi:10.3310/hta7110 · Cited by 585
Self-citationWald, N. J., Watt, H. C., & Hackshaw, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410701 · Cited by 530
Self-citationCombining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD
Hallan, S. I., Ritz, E., Lydersen, S., Romundstad, S., Kvenild, K., & Orth, S. R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070730 · Cited by 439
Metadata
- Authors
- Wald, N. J., Kennard, A., Hackshaw, A., & McGuire, A.
- Venue
- Journal of Medical Screening
- Publisher
- SAGE Publications
- Published
- 1997-12
- Volume
- 4
- Issue
- 4
- Pages
- 181-246
- ISSN
- 0969-1413 (ISSN-L)
- 1475-5793
- OpenAlex
- W2412527470
- Cited by
- 406
- References
- 104
- FWCI
- 20.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.